Please login to the form below

Algeta

This page shows the latest Algeta news and features for those working in and with pharma, biotech and healthcare.

He has held roles for Keryx Biopharmaceutical, Algeta ASA and AVEO Oncology.

Bayer CEO Dekkers points to 'outstanding' pharma growth

9bn it paid for the drug's developer Algeta last December.
Bayer buys Chinese consumer care company

Acquires Dihon Pharmaceutical as Algeta takeover closes. . Bayer has boosted its consumer healthcare operations in emerging markets with a deal to acquire China-based Dihon Pharmaceutical Group. ... year. By the extended deadline of February 26 the
Bayer agrees $2.9bn deal for Algeta to get Xofigo control

The bid represents a premium of 37 per cent over Algeta's closing price on November 25 when the initial offer was made. ... Algeta chief executive Andrew Kay said last month the drug had shown "excellent momentum" thanks to rapid endorsement by the US
Bayer offers $2.4bn to buy Xofigo partner Algeta

Algeta made the announcement after reports in the media suggested Bayer was offering NOK 306 per share for the company. ... One unanswered question is whether Algeta has some other hidden gems in its pipeline.
EU approval for Bayer’s prostate cancer drug

Bayer acquired Xofigo from Norwegian company Algeta in 2009. The deal granted full commercialisation rights in Europe to Bayer while in the US Bayer co-promotes the drug with Algeta.

More from news
Approximately 4 fully matching, plus 6 partially matching documents found.

Pharma deals during June 2014

Bayer paid 50m ($68m) upfront payment with further milestones in return for global rights which should complement Xofigo (from the acquisition of Algeta). The companies will jointly fund the phase III
Deal Watch table for November 2013

Hyperlipidemia. 2, 600. Algeta / Bayer. Acquisition. Buys out deal for Xofigo radiotherapeutic for.
Pharma deals during November 2013

Algeta, has been noted as being rather ungenerous, with room for upping the offer. This takeover was an obvious tactic bringing in the key the asset, Xofigo which has been under ... with Algeta under which there was US co-promotion for 50 per cent of

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Targovax appoints chief financial officer

He also brings experience from cancer biotech Algeta ASA, and management consulting expertise from McKinsey &Company's pharma and healthcare practice.
Targovax appoints Oystein Soug as CEO

He has previously served as chief financial officer for Algeta, a Norwegian oncology biotech that was bought by Bayer in 2014, and spent six years at Orkla, a Norwegian consumer goods
Algeta execs join Targovax

Anna-Kirsti Aksnes and Tina Madsen join the firm. Norway's Targovax has added to its senior team with the appointment of two executives from Algeta. ... Aksnes was most recently VP clinical research at Algeta, which was taken over by pharma giant Bayer

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Hybrid Role - Principal Medical Writer / Account Handler - Publi...: Salary TBC

Project Manager - Digital Healthcare - London: Excellent Remuneration Package

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Senior Account Director/ Associate Director- Pharma and Life Sci...: Competitive salary and benefits

Senior Account Manager- Pharma and Life Scienes: Competitive salary and benefits

Experienced / Senior Account Director - Publications - London: Up to £80, 000 plus great benefits

Project Manager - Medical Communications – South Wales: Excellent Remuneration Package

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Editorial / Copy Lead – Healthcare Advertising – Central London...: Salary TBC

Freelance Medical Writer - Healthcare Advertising - London: Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day

Senior / Principal Medical Writer - MedComms - Home Based / Vari...: Excellent Remuneration Packages

Account Manager / Senior Account Manager - Healthcare Advertisin...: Excellent Remuneration

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Add my company

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality: How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA: Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad: Six behaviours separate the good brand teams from the bad...